16-110604-T-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001077350.3(NPRL3):​c.550A>C​(p.Asn184His) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00671 in 1,607,092 control chromosomes in the GnomAD database, including 145 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/17 in silico tools predict a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. N184N) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.015 ( 43 hom., cov: 32)
Exomes 𝑓: 0.0058 ( 102 hom. )

Consequence

NPRL3
NM_001077350.3 missense, splice_region

Scores

15

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 1.04

Publications

0 publications found
Variant links:
Genes affected
NPRL3 (HGNC:14124): (NPR3 like, GATOR1 complex subunit) Contributes to GTPase activator activity. Involved in cellular response to amino acid starvation and negative regulation of TOR signaling. Located in lysosomal membrane. Part of GATOR1 complex. Implicated in focal epilepsy. [provided by Alliance of Genome Resources, Apr 2022]
NPRL3 Gene-Disease associations (from GenCC):
  • focal epilepsy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • epilepsy, familial focal, with variable foci 3
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • familial focal epilepsy with variable foci
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0032077432).
BP6
Variant 16-110604-T-G is Benign according to our data. Variant chr16-110604-T-G is described in ClinVar as Benign. ClinVar VariationId is 476225.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.015 (2286/152270) while in subpopulation AFR AF = 0.0334 (1389/41556). AF 95% confidence interval is 0.032. There are 43 homozygotes in GnomAd4. There are 1202 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 2286 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NPRL3NM_001077350.3 linkc.550A>C p.Asn184His missense_variant, splice_region_variant Exon 7 of 14 ENST00000611875.5 NP_001070818.1 Q12980Q9BTE2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NPRL3ENST00000611875.5 linkc.550A>C p.Asn184His missense_variant, splice_region_variant Exon 7 of 14 5 NM_001077350.3 ENSP00000478273.1 Q12980

Frequencies

GnomAD3 genomes
AF:
0.0150
AC:
2276
AN:
152152
Hom.:
41
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0333
Gnomad AMI
AF:
0.00877
Gnomad AMR
AF:
0.00668
Gnomad ASJ
AF:
0.00259
Gnomad EAS
AF:
0.00270
Gnomad SAS
AF:
0.0126
Gnomad FIN
AF:
0.0372
Gnomad MID
AF:
0.0222
Gnomad NFE
AF:
0.00395
Gnomad OTH
AF:
0.0153
GnomAD2 exomes
AF:
0.00927
AC:
2203
AN:
237606
AF XY:
0.00912
show subpopulations
Gnomad AFR exome
AF:
0.0317
Gnomad AMR exome
AF:
0.00421
Gnomad ASJ exome
AF:
0.00133
Gnomad EAS exome
AF:
0.000459
Gnomad FIN exome
AF:
0.0308
Gnomad NFE exome
AF:
0.00454
Gnomad OTH exome
AF:
0.00646
GnomAD4 exome
AF:
0.00584
AC:
8502
AN:
1454822
Hom.:
102
Cov.:
30
AF XY:
0.00613
AC XY:
4430
AN XY:
723038
show subpopulations
African (AFR)
AF:
0.0369
AC:
1230
AN:
33336
American (AMR)
AF:
0.00402
AC:
176
AN:
43824
Ashkenazi Jewish (ASJ)
AF:
0.00150
AC:
39
AN:
25926
East Asian (EAS)
AF:
0.000328
AC:
13
AN:
39602
South Asian (SAS)
AF:
0.0147
AC:
1244
AN:
84716
European-Finnish (FIN)
AF:
0.0303
AC:
1609
AN:
53036
Middle Eastern (MID)
AF:
0.0103
AC:
59
AN:
5756
European-Non Finnish (NFE)
AF:
0.00328
AC:
3633
AN:
1108470
Other (OTH)
AF:
0.00830
AC:
499
AN:
60156
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
360
719
1079
1438
1798
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
156
312
468
624
780
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0150
AC:
2286
AN:
152270
Hom.:
43
Cov.:
32
AF XY:
0.0161
AC XY:
1202
AN XY:
74468
show subpopulations
African (AFR)
AF:
0.0334
AC:
1389
AN:
41556
American (AMR)
AF:
0.00667
AC:
102
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00259
AC:
9
AN:
3470
East Asian (EAS)
AF:
0.00271
AC:
14
AN:
5174
South Asian (SAS)
AF:
0.0126
AC:
61
AN:
4824
European-Finnish (FIN)
AF:
0.0372
AC:
395
AN:
10612
Middle Eastern (MID)
AF:
0.0238
AC:
7
AN:
294
European-Non Finnish (NFE)
AF:
0.00395
AC:
269
AN:
68022
Other (OTH)
AF:
0.0151
AC:
32
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
118
235
353
470
588
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00750
Hom.:
11
Bravo
AF:
0.0130
TwinsUK
AF:
0.00162
AC:
6
ALSPAC
AF:
0.00649
AC:
25
ESP6500AA
AF:
0.0262
AC:
105
ESP6500EA
AF:
0.00289
AC:
24
ExAC
AF:
0.00963
AC:
1164
Asia WGS
AF:
0.0220
AC:
78
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Sep 14, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Epilepsy, familial focal, with variable foci 3 Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.063
BayesDel_addAF
Benign
-0.64
T
BayesDel_noAF
Benign
-0.66
CADD
Benign
18
DANN
Benign
0.92
DEOGEN2
Benign
0.093
T;.;T;.
Eigen
Benign
-0.038
Eigen_PC
Benign
-0.22
FATHMM_MKL
Benign
0.51
D
LIST_S2
Benign
0.84
T;T;.;T
MetaRNN
Benign
0.0032
T;T;T;T
MetaSVM
Benign
-1.1
T
PhyloP100
1.0
PrimateAI
Benign
0.38
T
REVEL
Benign
0.051
Sift4G
Benign
0.43
T;T;T;.
Polyphen
0.51
P;B;P;.
Vest4
0.15
MVP
0.18
MPC
0.26
ClinPred
0.0049
T
GERP RS
0.58
Varity_R
0.079
gMVP
0.22
Mutation Taster
=90/10
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs73478320; hg19: chr16-160602; API